课题基金 / 基金详情

Experimental and Clinical Studies on the Significance of Endothelium-Derived Hyperpolarizing Factor (EDHF)

Experimental and Clinical Studies on the Significance of Endothelium-Derived Hyperpolarizing Factor (EDHF)
内皮源性超极化因子(EDHF)意义的实验和临床研究
批准号:
16209027
负责人:
SHIMOKAWA Hiroaki
金额:
$30.7万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2006

项目摘要

项目成果

SHIMOKAWA Hiroaki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
1.Role of Endothelial NO synthases system in the production of EDHF/H_2_O2(1)We have demonstrated that endothelial Cu, Zn-SOD plays an important role in the synthesis of EDHF/H_2O_2 not only in animals but also in humans.(2)We have demonstrated that long-term inhibition of Rho-kinase, which down-regulates eNOS, ameliorates endothelial function in various animal models of cardiovascular diseases.(3)We have demonstrated that EDHF/H_2O_2 is involved in the effects of ACE inhibitors.(4)We have developed mice lacking all NO synthases. Those mice showed impaired survival with hypertension and myocardial infarction.(5)In those triply NOSs-KO mice, EDHF responses were abolished, demonstrating the importance of endothelial NOSs system in the synthesis of EDHF/H_2O_2.2.Mechanisms of Physiological and Pathological H_2O_2 Synthesis(1)We were able to demonstrate that endothelial cells release H_2O_2 and NO at p.M order and that the two factors interact synergistically to maintain coronary flow in dogs in vivo.(2)We have demonstrated that other endothelial oxidases system (e.g.NADPH) are not involved in the EDHF/H_2O_2 responses.3.In vivo imaging of H_2O_2We were able to demonstrate endothelial production of H_2O_2 using DCF fluorescence imaging in vivo.4.Role of EDHF/H_2O_2 in animalsWe have demonstrated that EDHF/H_2O_2 plays an important protective role in myocardial ischemia/reperfusion and metabolic coronary vasodilatation as well.5.Role of EDHF/H_2O_2 in humans(1)We have demonstrated that in cultured vascular smooth muscle cells from human coronary arteries, estrogen down-regulates while nicotine up-regulates Rho-kinase.(2)We have demonstrated that selective Rho-kinase inhibitors acutely reduces pulmonary vascular resistance without systemic hemodynamic effects in patients with pulmonary hypertension.
期刊论文(29)
专著(0)
科研奖励(0)
会议论文
内皮由来過分極因子と内皮機能障害
内皮源性超极化因子和内皮功能障碍
DOI: --
发表时间: 2006
期刊: 日本臨床 64
影响因子: --
作者: [高木文, 下川宏明]
通讯作者: 下川宏明
Important role of hydrogen peroxide in pacing-induced metabolic coronary vasodilatation in dogs in vivo.
过氧化氢在狗体内起搏诱导的代谢性冠状血管舒张中的重要作用。
DOI: --
发表时间: 2007
期刊: Journal of the American College of Cardiolgy (in press)
影响因子: --
作者: [Yada T, Shimokawa H, et al.]
通讯作者: et al.
DOI: 10.1161/01.res.0000244093.69985.2f
发表时间: 2006-09-29
期刊: CIRCULATION RESEARCH
影响因子: 20.1
作者: [Hizume, Takatoshi, Morikawa, Keiko, Shimokawa, Hiroaki]
通讯作者: Shimokawa, Hiroaki
内科学(第9版) 欠陥の収縮弛緩と血圧調節機構
内科学(第9版)收缩/舒张缺陷与血压调节机制
DOI: --
发表时间: 2006
期刊:
影响因子: --
作者: [Ishii K, Tamaoka A, Otsuka F, Iwasaki N, Shin K, Matsui A, Endo G, Kumagai Y, Ishii T, Shoji S, Ogata T, Ishizaki M, Doi M, Shimojo N., 石崎 貴裕, Fukasawa M ed. al., 下川宏明]
通讯作者: 下川宏明
15
    The possibility of pleiotropic effects of Novel Oral Anticoagulants (NOAC) on Rho-kinase-cyclophilin A System
    • 批准号:
      25670379
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2013
    • 负责人:
      SHIMOKAWA Hiroaki
    • 依托单位:
    The role of SmgGDS in the pleiotropic effects by statins
    • 批准号:
      23659071
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2011
    • 负责人:
      SHIMOKAWA Hiroaki
    • 依托单位:
    Molecular mechanisms for NOSs-mediated responses in microvessels
    • 批准号:
      22390154
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.9万
    • 财政年份:
      2010
    • 负责人:
      SHIMOKAWA Hiroaki
    • 依托单位:
    International Collaboration Study on the Racial Difference in Coronary Vasospasm
    海外基金